2013
DOI: 10.1016/j.etp.2011.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
26
0
2

Year Published

2013
2013
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(30 citation statements)
references
References 35 publications
2
26
0
2
Order By: Relevance
“…This finding is consistent with earlier studies where GSH depletion was suggested to result from interaction between cisplatin and biomolecules containing sulphydryl groups (Khoshnoud et al, 2011;Mohamed et al, 2013). Likewise, the reduced kidney vitamin C content in the cisplatin administered rats may be related to depleted GSH storage because, GSH is necessary for the recycling of vitamin C (Murray et al, 2003).…”
Section: Groupsupporting
confidence: 82%
“…This finding is consistent with earlier studies where GSH depletion was suggested to result from interaction between cisplatin and biomolecules containing sulphydryl groups (Khoshnoud et al, 2011;Mohamed et al, 2013). Likewise, the reduced kidney vitamin C content in the cisplatin administered rats may be related to depleted GSH storage because, GSH is necessary for the recycling of vitamin C (Murray et al, 2003).…”
Section: Groupsupporting
confidence: 82%
“…CDDP resulted in significant tubular damage[28] and oxidative stress involved in kidney damage after CDDP administration. [30] The nephrotoxic effect of CDDP is related to its uptake by proximal tubular cells.…”
Section: Discussionmentioning
confidence: 99%
“…The demonstrated presence of EPO receptor in nonhematopoietic tissues has led researchers to examine the potential beneficial effects of EPO, apart from its hematopoietic function, and the cytoprotective effects of EPO have been demonstrated extensively in various tissues. In these studies, rhEPO (recombinant human erythropoietin) has been found to be protective against both ischemic and toxic injuries, such as ischemic brain and myocardial injury [12,13] and CDDP-induced kidney and liver injury [14,15] . In addition, it has also been demonstrated that EPO and its receptors are widely expressed in several cell types within the cochlea, and EPO was found to be protective against gentamicin-induced hair cell damage in rat cochlea cell lines [16] .…”
Section: Introductionmentioning
confidence: 99%